Fig. 6From: Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell lineApical to basolateral transport of [125I]-angiopep-2. Transport (left) and uptake (right) of [125I]-angiopep-2 were measured in the absence and presence of the non-labeled angiopep-2 (cold) over a time course of four hours. The cell uptake was probed after the transport study was terminated. Data are shown as mean ± SEM of three individual passages of triplicates (n = 3, N = 3). **: p < 0.005Back to article page